Healthcare & Life Sciences
ILC Therapeutics
United Kingdomilctherapeutics.com/about-us/overview.asp
ILC Therapeutics is a Healthcare & Life Sciences startup based in the United Kingdom, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About ILC Therapeutics
ILC Therapeutics is a company headquartered in the United Kingdom. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
ILC Therapeutics is a UK-based company that designs and develops engineered hybrid interferons, a novel class of cytokine therapeutics aimed at reducing toxicity and improving efficacy, initially focusing on infectious diseases.
Explore ILC Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.